係未兩隻都係FDA試緊?
https://www.cassiopea.com/company/#Newsroom
// Breezula is under investigation in the United States for the treatment of androgenetic alopecia, and the safety and efficacy have not been established by the United States Food and Drug Administration (FDA). The proposed brand name for clascoterone solution 7.5% is not FDA-approved.
Winlevi is under investigation in the United States for the treatment of acne, and the safety and efficacy have not been established by the United States Food and Drug Administration (FDA). The proposed brand name for clascoterone cream 1% is not FDA-approved.//
Cassiopea Announces Very Positive Phase II Twelve Months Results for Breezula® (Clascoterone) in Treating Androgenetic Alopecia, April 16, 2019
唔知幾時有phase III睇
但我上網睇啲人話以前有個叫RU-58841都差唔多原理,但搞搞下無人研究

究竟發生咩事